CLINICAL_TRIALS
trial_result
· 2021-06-18
Clinical Trial Update: A Study That Looks at the Function of the Heart in Patients With Heart Failure Who Take Empagliflozin [Phase 3]
Summary
Phase 3 trial update evaluating the effect of empagliflozin on heart function in patients with heart failure has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2021-06-18